Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial
Nasser K. Altorki(NewYork–Presbyterian Hospital), Timothy E. McGraw(NewYork–Presbyterian Hospital), Alain Borczuk(NewYork–Presbyterian Hospital), Ashish Saxena(NewYork–Presbyterian Hospital), Jeffrey L. Port(NewYork–Presbyterian Hospital), Brendon M. Stiles(NewYork–Presbyterian Hospital), Benjamin E. Lee(NewYork–Presbyterian Hospital), Nicholas J Sanfilippo(NewYork–Presbyterian Hospital), Ronald Scheff(NewYork–Presbyterian Hospital), Bradley B. Pua(NewYork–Presbyterian Hospital), James F. Gruden(NewYork–Presbyterian Hospital), Paul J. Christos(NewYork–Presbyterian Hospital), Cathy Spinelli(NewYork–Presbyterian Hospital), Joyce Gakuria(NewYork–Presbyterian Hospital), Manik Uppal(NewYork–Presbyterian Hospital), Bhavneet Binder(NewYork–Presbyterian Hospital), Olivier Elemento(NewYork–Presbyterian Hospital), Karla V. Ballman(NewYork–Presbyterian Hospital), Silvia C. Formenti(NewYork–Presbyterian Hospital)
Cited by 328
Abstract
Related Papers
No related papers found
Powered by citation graph analysis